Goldman Sachs added Amazon and Huntington Ingalls to its Conviction List for October, despite both having lackluster years so ...

With potential profit-taking on the horizon, it could mean Moderna stock's upside is limited in the short-term.

Synopsys stock rose after the company's investor day presentation focused on growth from AI-assisted chip design tools.

Biotech leader BeOne stock is poised to hit multiple buy points. Its blockbuster drug generated $1.2 billion in sales in the ...

DOD launches new readiness initiatives, autonomous warfare program. SpaceX's Elon Musk, Anduril's Palmer Luckey involved.

SpaceX CEO Elon Musk this week slashed expectations for the number of Starship launches next year following the flight 14 ...

Micron Technology (MU) delivered a sizable beat-and-raise earnings report, but it didn't do much for Micron stock as ...

The country's EV companies released their monthly delivery numbers for September. Some reached individual milestones, while ...

Amazon signed a 20-year nuclear power supply deal with Constellation Energy, putting CEG stock among the day's S&P 500 ...

Nektar stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients.

Oracle stock wavered following a report the tech giant landed a $7 billion deal to provide cloud-computing services to ...

Moderna and Merck are eyeing a multi-billion-dollar market with their personalized mRNA cancer vaccine. But Wall Street ...